I heard a lot of concerns from pharma lawyers this week about this stuff. How did we get to the point where our companies are selling stuff overseas at a lower profit than they sell it here? Was this negotiated by our administration and, if so, did our allies threaten to otherwise copy the drugs if we didn't sell it on the cheap? I'm serious, as I don't know the answer. To restate the question, what was Canada and Europe's negotiating position in this?
If they took the position that they would copy and/or ignore intellectual property, than along with defense spending, I think we've been given more than enough reason to start fighting back against the socialists and other freeloaders. But I may be wrong insofar as I don't know how we got to this point...
Hello
